175 related articles for article (PubMed ID: 14510261)
1. Contrast-enhanced agent detection imaging: value in the characterization of focal hepatic lesions.
Youk JH; Kim CS; Lee JM
J Ultrasound Med; 2003 Sep; 22(9):897-910. PubMed ID: 14510261
[TBL] [Abstract][Full Text] [Related]
2. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US.
Dill-Macky MJ; Burns PN; Khalili K; Wilson SR
Radiology; 2002 Jan; 222(1):95-102. PubMed ID: 11756711
[TBL] [Abstract][Full Text] [Related]
3. Focal hepatic lesions: evaluation with contrast-enhanced gray-scale harmonic US.
Jang HJ; Lim HK; Lee WJ; Kim SH; Kim MJ; Choi D; Lee SJ; Lim JH
Korean J Radiol; 2003; 4(2):91-100. PubMed ID: 12845304
[TBL] [Abstract][Full Text] [Related]
4. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio.
Wen YL; Kudo M; Zheng RQ; Ding H; Zhou P; Minami Y; Chung H; Kitano M; Kawasaki T; Maekawa K
AJR Am J Roentgenol; 2004 Apr; 182(4):1019-26. PubMed ID: 15039180
[TBL] [Abstract][Full Text] [Related]
5. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
6. Pulse inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions.
von Herbay A; Vogt C; Häussinger D
J Ultrasound Med; 2002 Nov; 21(11):1191-200. PubMed ID: 12418760
[TBL] [Abstract][Full Text] [Related]
7. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
8. Focal hepatic lesions: contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent.
Kim EA; Yoon KH; Lee YH; Kim HW; Juhng SK; Won JJ
Korean J Radiol; 2003; 4(4):224-33. PubMed ID: 14726639
[TBL] [Abstract][Full Text] [Related]
9. [Value of combined conventional and contrast enhanced sonography in the evaluation of hepatic disorders].
Tranquart F; Bleuzen A; Kissel A
J Radiol; 2004 Jun; 85(6 Pt 1):755-62. PubMed ID: 15243376
[TBL] [Abstract][Full Text] [Related]
10. US characterization of focal hepatic lesions with intermittent high-acoustic-power mode and contrast material.
Quaia E; Bertolotto M; Calderan L; Mosconi E; Mucelli RP
Acad Radiol; 2003 Jul; 10(7):739-50. PubMed ID: 12862283
[TBL] [Abstract][Full Text] [Related]
11. Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions.
Quillin SP; Atilla S; Brown JJ; Borrello JA; Yu CY; Pilgram TK
Magn Reson Imaging; 1997; 15(3):275-85. PubMed ID: 9201674
[TBL] [Abstract][Full Text] [Related]
12. Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT.
Nino-Murcia M; Olcott EW; Jeffrey RB; Lamm RL; Beaulieu CF; Jain KA
Radiology; 2000 Jun; 215(3):746-51. PubMed ID: 10831693
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of hepatic focal nodular hyperplasia with contrast-enhanced gray scale harmonic sonography: initial experience.
Kim MJ; Lim HK; Kim SH; Choi D; Lee WJ; Lee SJ; Lim JH
J Ultrasound Med; 2004 Feb; 23(2):297-305. PubMed ID: 14992369
[TBL] [Abstract][Full Text] [Related]
14. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US.
Kim TK; Choi BI; Han JK; Hong HS; Park SH; Moon SG
Radiology; 2000 Aug; 216(2):411-7. PubMed ID: 10924562
[TBL] [Abstract][Full Text] [Related]
15. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results.
Bertolotto M; Dalla Palma L; Quaia E; Locatelli M
Eur Radiol; 2000; 10(9):1369-76. PubMed ID: 10997422
[TBL] [Abstract][Full Text] [Related]
16. Do different types of liver lesions differ in their uptake of the microbubble contrast agent SH U 508A in the late liver phase? Early experience.
Blomley MJ; Sidhu PS; Cosgrove DO; Albrecht T; Harvey CJ; Heckemann RA; Butler-Barnes J; Eckersley RJ; Basilico R
Radiology; 2001 Sep; 220(3):661-7. PubMed ID: 11526264
[TBL] [Abstract][Full Text] [Related]
17. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
[TBL] [Abstract][Full Text] [Related]
18. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis.
Wilson SR; Burns PN; Muradali D; Wilson JA; Lai X
Radiology; 2000 Apr; 215(1):153-61. PubMed ID: 10751481
[TBL] [Abstract][Full Text] [Related]
19. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions.
von Herbay A; Vogt C; Willers R; Häussinger D
J Ultrasound Med; 2004 Dec; 23(12):1557-68. PubMed ID: 15557299
[TBL] [Abstract][Full Text] [Related]
20. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
